title: Oral graft-versus-host disease.
abstract: Allogeneic hematopoietic cell transplantation (allo-HCT) is used for the treatment of a variety of disorders, primarily hematologic malignancies. Graft-versus-host disease (GVHD) is a significant complication following allo-HCT and a major cause of morbidity and mortality. The oral cavity is frequently involved in GVHD, leading to pain, functional impairment, and reduced quality of life. Early diagnosis, management, and long-term follow-up of oral GVHD are important components of overall patient care.
authors.affiliation: Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115, USA.
authors.forename: Michal
authors.initials: M
authors.lastname: Kuten-Shorrer
authors.affiliation: Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, 1620 Tremont Street, 3rd Floor, Boston, MA 02115, USA.
authors.forename: Sook-Bin
authors.initials: SB
authors.lastname: Woo
authors.affiliation: Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, 1620 Tremont Street, 3rd Floor, Boston, MA 02115, USA. Electronic address: ntreister@partners.org.
authors.forename: Nathaniel S
authors.initials: NS
authors.lastname: Treister
mesh_terms: D064591:Allografts / Q000637:transplantation; D003937:Diagnosis, Differential; D042241:Early Diagnosis; D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000628:therapy; D019337:Hematologic Neoplasms / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009059:Mouth Diseases / Q000175:diagnosis* / Q000628:therapy; D011788:Quality of Life; D019172:Transplantation Conditioning / Q000009:adverse effects
keywords: Allogeneic; GVHD; Graft-versus-host disease; Hematopoietic cell transplantation; Oral mucosal disease